Cell-free Fetal DNA Testing Market

The Cell-free fetal DNA testing market is reported to reach a valuation of USD 1,687.8 million in 2025 to USD 3,051.5 million by 2035. In 2025, monoclonal antibodies hold significant market share of 78.3% in the year 2025. In 2025, Cell-Free DNA Extraction & Purification Kits are expected to lead with a 49.5% share, driven by the need for high-quality fetal DNA isolation. Maternal Plasma/Serum will dominate the sample type segment with 95.2% share, supported by its proven reliability in non-invasive fetal DNA testing.